Knobbe Martens Partners Recognized as Top IP Strategists in 2025 IAM Strategy 300 Guide
IRVINE, Calif., August 14, 2025 – Knobbe Martens is pleased to share that a number of the firm’s partners have been recognized in the 2025 edition of the IAM Strategy...
Knobbe Martens, Dozens of Firm Partners Recognized in Legal 500 U.S.A. Guide
Firm again receives standout rankings in multiple practice areas, including prosecution, trademarks, licensing, and litigation IRVINE, Calif., June 17, 2025 – Knobbe Martens is proud to announce that the firm...
David Schmidt and Zachary Grinovich Author World IP Review Article on NPE Litigation at the UPC
In the article “Non-practicing Entity Litigation at the UPC: A US Perspective,” lawyers David Schmidt, PhD and Zachary Grinovich explore recent developments at the Unified Patent Court that could impact...
Getinge Acquires Paragonix Technologies
Getinge, a Swedish public limited company, announced on September 11, 2024 that it completed acquisition of Paragonix Technologies, Inc., a U.S. company specializing in organ transport products and services. According to Getinge’s press release, the total purchase price was $477 million.
Knobbe Martens Advises Paragonix Technologies in Definitive Agreement to be Acquired by Getinge
IRVINE, Calif., August 23, 2024 – Paragonix Technologies, a leading organ transplant company, announced today that it has entered into a definitive agreement to be acquired by Getinge. A team...
Sixty Knobbe Martens Attorneys Recognized in “Best Lawyers” 2025 Guide
IRVINE, Calif., August 15, 2024 – Knobbe Martens is pleased to share that Best Lawyers in America has included 60 of the firm’s lawyers in its 2025 Guide. The recognized...
Dozens of Knobbe Martens Partners and Practices Receive Standout Rankings from Legal 500
The firm and its partners were recognized for strengths across all areas of IP, including patent prosecution, trademarks, and patent litigation—including ITC litigation IRVINE, Calif., June 17, 2024 – Knobbe...
In Managing IP Article, Dr. David Schmidt Discusses How Knobbe Martens is Helping Clients Navigate the UPC
In the Managing IP article “Strengthening Ties: How US Firms Are Responding to the UPC,” partner Dr. David Schmidt shared how the firm is helping clients understand and adapt to...
Knobbe Martens Obtains Favorable Ruling for Japanese Materials and Chemical Manufacturer in Post Grant Review Proceeding
Patent and Trial Appeals Board invalidates 15 claims in patent held by Fujifilm San Diego, Calif., June 23, 2023 – A Knobbe Martens team led by Nathanael Luman, Ph.D. secured...
Knobbe Martens Advises Signet Healthcare Partners in Leading $24 Million Series B Funding of Paragonix Technologies
Irvine, Calif., March 7, 2023 – Paragonix Technologies, Inc., a leading organ transplant company, today announced that it has secured $24 million in Series B funding, led by Signet Healthcare...
Strategic Considerations for Claim Drafting: Chemical Inventions – Knobbe Practice Webinar Series
Partners Dan Altman and David Schmidt, Ph.D. gave an informative presentation on strategic considerations for claim drafting chemical inventions. The partners provided insights related to effective and efficient patent prosecution...
Strategic Considerations for Claim Drafting – Mechanical and Medical Device Inventions – Knobbe Practice Webinar Series
Partners David Schmidt, Ph.D. and Jessica Achtsam presented strategic considerations for drafting and prosecuting patent claims directed to mechanical and medical device inventions, before the United States Patent and Trademark...
Current State of the U.S. Patent Law: Risk Mitigation Based on Legal Opinions – Knobbe Practice Webinar Series
Knobbe Practice Japan Webinar Series Partners Mauricio Uribe, Dan Altman and David Schmidt, Ph.D., gave a presentation focused on understanding the history and current state of the law involving willful...
Strategic Considerations for Life Science Claim Drafting – Knobbe Practice Webinar Series
Partners Dan Altman, David Schmidt, Ph.D. and Jessica Achtsam gave an informative presentation on strategic considerations for claim drafting life sciences inventions. The partners provided insights related to effective and efficient...
Strategic Considerations for Life Sciences/Pharma Inventions Claim Drafting with Summary in Japanese by IP Strategist Kenny Masaki – Knobbe Practice Webinar Series
Partners Dan Altman and David Schmidt, Ph.D., gave an informative presentation focused on strategic considerations for drafting and prosecuting patent claims directed to life sciences-related inventions, before the United States...
7 Expert Insights on Packaging IP and Patents
Partners Sabing Lee and David Schmidt, Ph.D were interviewed in “7 Expert Insights on Packaging IP and Patents,” which was published in two online publications, Plastics Today and Packaging Digest. Excerpt:...
Knobbe Practice Webinar Series: Strategic Considerations in Controlling Speed of Prosecution in USPTO
Partners Mauricio Uribe, David Schmidt and Vlad Teplitskiy presented a webinar focused on strategic considerations in controlling speed of prosecution in USPTO. View live presentation: Video Link Knobbe Martens on Vimeo...
Knobbe Martens Webinar Series: Strategic Considerations in Controlling the Speed of Prosecution at the USPTO
Attorneys David Schmidt, Ph.D., Heungsoo Choi, and Of Counsel Hironori Kubota presented a detailed webinar focusing on Strategic Considerations in Controlling the Speed of Prosecution at the USPTO.
Knobbe Martens Webinar Series: Strategic Considerations in Conducting Examiner Interviews
Partners Mauricio Uribe and David Schmidt presented a webinar focused on strategic considerations in conducting examiner interviews.
Knobbe Practice Webinar Series: Strategic Considerations in Conducting Interviews at the U.S. Patent Office
Attorneys David Schmidt, Ph.D., Heungsoo Choi, and Of Counsel Hironori Kubota presented a detailed webinar focusing on strategic considerations in conducting patent examiner interviews in support of the prosecution of patent applications in the United States.
